ClinicalTrials.Veeva

Menu

Microbiological Assessment After Chemo-Mechanical Caries Removal Using Papain-based Enzyme Versus Conventional Rotary Tools in Occlusal Carious Lesions

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Microbial Colonization

Treatments

Drug: Papain-based Chemo-mechanical caries removal agent
Device: conventional rotary

Study type

Interventional

Funder types

Other

Identifiers

NCT03408626
CEBC-CU-2017-12-28

Details and patient eligibility

About

This study will be conducted to assess the efficacy of caries excavation using the papain-based chemo-mechanical method (Brix 3000) in comparison to conventional rotary tools in the reduction of the bacterial population in occlusal carious cavities

Full description

Twenty-three patients who will fulfill the inclusion criteria will be enrolled to the study. For every patient two contra-lateral class I carious molars will be selected, so the total number of included molars will be 46 molars. One contra-lateral molar will be randomly assigned to the chemo-mechanical (Brix 3000) caries removal technique and the other will be assigned to the conventional rotary one. From every molar two dentin specimens will be collected (baseline and after excavation) with a total of 92 samples

Enrollment

2 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Class I carious lesions
  2. Lower molars
  3. Bilateral lesions
  4. 18 -50 years
  5. Males or Females (Both genders)
  6. Good oral hygiene
  7. Co-operative patients approving the trial

Exclusion criteria

  1. Pregnancy
  2. Systemic disease or severe medical complications
  3. Periodontal problem
  4. Mobile teeth, arrest caries and non-vital teeth
  5. Smokers
  6. Xerostomia
  7. Lack of compliance
  8. Not received antibiotic therapy since 1 month before sampling

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2 participants in 2 patient groups, including a placebo group

papain chemomechenical caries removal agent (brix 3000)
Experimental group
Description:
papain chemomechenical caries removal agent (Birx 3000) and the exclusive Encapsulating Buffer Emulsifier (EBE) technology claim it has effective and selective proteolytic action
Treatment:
Device: conventional rotary
Drug: Papain-based Chemo-mechanical caries removal agent
conventional
Placebo Comparator group
Description:
conventional 330 bur
Treatment:
Device: conventional rotary
Drug: Papain-based Chemo-mechanical caries removal agent

Trial contacts and locations

0

Loading...

Central trial contact

laila akmal emad eldin elokaly, master; laila akml emad eldin elokaly, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems